{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T12:18:54Z","timestamp":1792930734511,"version":"4.5.0"},"reference-count":63,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T00:00:00Z","timestamp":1718236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>The increasing utilization of Glucagon-like Peptide-1 receptor agonists (GLP-1 RAs) in managing type 2 diabetes mellitus has raised interest regarding their impact on thyroid function. In fact, while these agents are well known for their efficacy in glycemic control and weight management, their association with thyroid disorders requires clarification due to the complex interplay between thyroid hormones and metabolic pathways. Thyroid dysfunction commonly co-occurs with metabolic conditions such as diabetes and obesity, suggesting a profound interconnection between these systems. This review aims to contribute to a deeper understanding of the interaction between GLP-1 RAs and thyroid dysfunction and to clarify the safety of GLP-1 RAs in diabetic patients with thyroid disorders. By synthesizing existing evidence, this review highlights that, despite various studies exploring this topic, current evidence is inconclusive, with conflicting results. It is important to note that these drugs are relatively recent, and longer-term studies with larger sample sizes are likely needed to draw clearer conclusions. Currently, no existing guidelines provide definitive directions on this clinical issue; however, it is advisable to include thyroid function tests in the routine screening of diabetic patients, particularly those treated with GLP-1 Ras, with the goal of optimizing patient care and management.<\/jats:p>","DOI":"10.3390\/biom14060687","type":"journal-article","created":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T08:52:10Z","timestamp":1718355130000},"page":"687","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Implications of GLP-1 Receptor Agonist on Thyroid Function: A Literature Review of Its Effects on Thyroid Volume, Risk of Cancer, Functionality and TSH Levels"],"prefix":"10.3390","volume":"14","author":[{"given":"Stefania","family":"Capuccio","sequence":"first","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Catania, 95122 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9061-0368","authenticated-orcid":false,"given":"Sabrina","family":"Scilletta","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Catania, 95122 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"La Rocca","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Catania, 95122 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0429-9807","authenticated-orcid":false,"given":"Nicoletta","family":"Miano","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Catania, 95122 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9021-6101","authenticated-orcid":false,"given":"Maurizio","family":"Di Marco","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Catania, 95122 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6036-927X","authenticated-orcid":false,"given":"Giosiana","family":"Bosco","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Catania, 95122 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Di Giacomo Barbagallo","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Catania, 95122 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7023-3649","authenticated-orcid":false,"given":"Roberto","family":"Scicali","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Catania, 95122 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Piro","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Catania, 95122 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Di Pino","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Catania, 95122 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,6,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"R200","DOI":"10.1530\/EC-21-0130","article-title":"How Glucagon-like Peptide 1 Receptor Agonists Work","volume":"10","author":"Andreasen","year":"2021","journal-title":"Endocr. Connect."},{"key":"ref_2","first-page":"e20697","article-title":"The Relationship Between Type 2 Diabetes Mellitus and Related Thyroid Diseases","volume":"13","author":"AbdElmageed","year":"2021","journal-title":"Cureus"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1177\/0192623312472402","article-title":"On-Target Effects of GLP-1 Receptor Agonists on Thyroid C-Cells in Rats and Mice","volume":"41","author":"Rosol","year":"2013","journal-title":"Toxicol. Pathol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jdiacomp.2015.12.027","article-title":"Incidence and Prevalence of Thyroid Dysfunction in Type 1 Diabetes","volume":"30","author":"Nederstigt","year":"2016","journal-title":"J. Diabetes Complicat."},{"key":"ref_5","first-page":"355","article-title":"Prevalence of thyroid dysfunction in patients with type 2 diabetes mellitus","volume":"76","author":"Fregenal","year":"2016","journal-title":"Medicina"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1464-5491.1995.tb00553.x","article-title":"Frequency of Thyroid Dysfunction in Diabetic Patients: Value of Annual Screening","volume":"12","author":"Perros","year":"1995","journal-title":"Diabet. Med."},{"key":"ref_7","first-page":"75","article-title":"Prevalence of Thyroid Dysfunction among Greek Type 2 Diabetic Patients Attending an Outpatient Clinic","volume":"2","author":"Papazafiropoulou","year":"2010","journal-title":"J. Clin. Med. Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s00592-006-0204-8","article-title":"Thyroid Dysfunction and Thyroid Autoimmunity in Saudi Type 2 Diabetics","volume":"43","author":"Akbar","year":"2006","journal-title":"Acta Diabetol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1758-5996-5-58","article-title":"Prevalence of Thyroid Dysfunction in Patients with Diabetes Mellitus","volume":"5","author":"Palma","year":"2013","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_10","first-page":"1046","article-title":"Thyroid Dysfunction in Patients with Type 2 Diabetes Mellitus in Jordan","volume":"25","author":"Radaideh","year":"2004","journal-title":"Saudi Med. J."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Han, C., He, X., Xia, X., Li, Y., Shi, X., Shan, Z., and Teng, W. (2015). Subclinical Hypothyroidism and Type 2 Diabetes: A Systematic Review and Meta-Analysis. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0135233"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1172\/JCI60047","article-title":"Mechanisms of Thyroid Hormone Action","volume":"122","author":"Brent","year":"2012","journal-title":"J. Clin. Investig."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Yeo, Y., Ma, S.-H., Hwang, Y., Horn-Ross, P.L., Hsing, A., Lee, K.-E., Park, Y.J., Park, D.-J., Yoo, K.-Y., and Park, S.K. (2014). Diabetes Mellitus and Risk of Thyroid Cancer: A Meta-Analysis. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0098135"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1289\/ehp.106-1533202","article-title":"Recent Developments in the Investigation of Thyroid Regulation and Thyroid Carcinogenesis","volume":"106","author":"Hard","year":"1998","journal-title":"Environ. Health Perspect."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1089\/thy.2007.0223","article-title":"Introducing the Thyroid Gland as Another Victim of the Insulin Resistance Syndrome","volume":"18","author":"Rezzonico","year":"2008","journal-title":"Thyroid"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"806349","DOI":"10.3389\/fendo.2022.806349","article-title":"Abnormal Glucose Metabolism Parameters and the Aggressiveness of Differentiated Thyroid Carcinoma: A Hospital-Based Cross-Section Study in China","volume":"13","author":"Zhao","year":"2022","journal-title":"Front. Endocrinol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11154-023-09849-7","article-title":"Thyroid Cancer and Insulin Resistance","volume":"25","author":"Brenta","year":"2024","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Abu Arar, Y., Shilo, M., Bilenko, N., Friger, M., Marsha, H., Fisher, D., Fraenkel, M., and Yoel, U. (2024). Are Higher Body Mass Index and Worse Metabolic Parameters Associated with More Aggressive Differentiated Thyroid Cancer? A Retrospective Cohort Study. Healthcare, 12.","DOI":"10.3390\/healthcare12050581"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00592-014-0555-5","article-title":"Alpha- and Beta-Cell Abnormalities in Haemoglobin A1c-Defined Prediabetes and Type 2 Diabetes","volume":"51","author":"Calanna","year":"2014","journal-title":"Acta Diabetol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.metabol.2013.09.010","article-title":"Anti-Diabetic Actions of Glucagon-like Peptide-1 on Pancreatic Beta-Cells","volume":"63","author":"Lee","year":"2014","journal-title":"Metabolism"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/oby.20017","article-title":"Beta and Alpha Cell Function in Metabolically Healthy but Obese Subjects: Relationship with Entero-insular Axis","volume":"21","author":"Calanna","year":"2013","journal-title":"Obesity"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1152\/physrev.00034.2006","article-title":"The Physiology of Glucagon-like Peptide 1","volume":"87","author":"Holst","year":"2007","journal-title":"Physiol. Rev."},{"key":"ref_23","first-page":"1","article-title":"Physiology and Emerging Biochemistry of the Glucagon-Like Peptide-1 Receptor","volume":"2012","author":"Willard","year":"2012","journal-title":"Exp. Diabetes Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1002\/hep.23569","article-title":"Glucagon-like Peptide-1 Receptor Is Present on Human Hepatocytes and Has a Direct Role in Decreasing Hepatic Steatosis in Vitro by Modulating Elements of the Insulin Signaling Pathway","volume":"51","author":"Gupta","year":"2010","journal-title":"Hepatology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1210\/jc.2011-2407","article-title":"Glucagon like Peptide-1 Receptor Expression in the Human Thyroid Gland","volume":"97","author":"Gier","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"5621","DOI":"10.2147\/OTT.S150701","article-title":"Effects of Insulin Analogs and Glucagon-like Peptide-1 Receptor Agonists on Proliferation and Cellular Energy Metabolism in Papillary Thyroid Cancer","volume":"10","author":"He","year":"2017","journal-title":"OncoTargets Ther."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1530\/JME-12-0186","article-title":"Effect of GLP1R Agonists Taspoglutide and Liraglutide on Primary Thyroid C-Cells from Rodent and Man","volume":"50","author":"Boess","year":"2013","journal-title":"J. Mol. Endocrinol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e076410","DOI":"10.1136\/bmj-2023-076410","article-title":"Comparative Effectiveness of GLP-1 Receptor Agonists on Glycaemic Control, Body Weight, and Lipid Profile for Type 2 Diabetes: Systematic Review and Network Meta-Analysis","volume":"384","author":"Yao","year":"2024","journal-title":"BMJ"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1111\/imj.16126","article-title":"Weight Loss with Subcutaneous Semaglutide versus Other Glucagon-like Peptide 1 Receptor Agonists in Type 2 Diabetes: A Systematic Review","volume":"53","author":"Stretton","year":"2023","journal-title":"Intern. Med. J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1007\/s00125-022-05787-2","article-title":"Management of Hyperglycaemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"65","author":"Davies","year":"2022","journal-title":"Diabetologia"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/S0140-6736(09)61375-1","article-title":"NN8022-1807 Study Group Effects of Liraglutide in the Treatment of Obesity: A Randomised, Double-Blind, Placebo-Controlled Study","volume":"374","author":"Astrup","year":"2009","journal-title":"Lancet"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1186\/s12933-023-02065-2","article-title":"Cardiovascular Risk and Renal Injury Profile in Subjects with Type 2 Diabetes and Non-Albuminuric Diabetic Kidney Disease","volume":"22","author":"Scilletta","year":"2023","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Scilletta, S., Di Marco, M., Miano, N., Filippello, A., Di Mauro, S., Scamporrino, A., Musmeci, M., Coppolino, G., Di Giacomo Barbagallo, F., and Bosco, G. (2023). Update on Diabetic Kidney Disease (DKD): Focus on Non-Albuminuric DKD and Cardiovascular Risk. Biomolecules, 13.","DOI":"10.3390\/biom13050752"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1210\/endrev\/bnaa032","article-title":"Revisiting the Complexity of GLP-1 Action from Sites of Synthesis to Receptor Activation","volume":"42","author":"McLean","year":"2021","journal-title":"Endocr. Rev."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1080\/14656566.2023.2192865","article-title":"GLP-1\/GIP Analogs: Potential Impact in the Landscape of Obesity Pharmacotherapy","volume":"24","author":"Lafferty","year":"2023","journal-title":"Expert. Opin. Pharmacother."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"25","DOI":"10.7570\/jomes22067","article-title":"Efficacy and Safety of Tirzepatide in Type 2 Diabetes and Obesity Management","volume":"32","author":"Sinha","year":"2023","journal-title":"J. Obes. Metab. Syndr."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4158\/CS-2018-0535","article-title":"Consensus Statement by the American Association of Clinical Endrocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm\u20142019 Executive Summary","volume":"25","author":"Garber","year":"2019","journal-title":"Endocr. Pract."},{"key":"ref_38","unstructured":"(2024, January 16). Eli Lilly and Company Trulicity (Dulaglutide) Injection for Subcutaneous Use; Prescribing Information. Available online: https:\/\/pi.lilly.com\/us\/trulicity-uspi.pdf."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1159\/000501895","article-title":"The Effect of Exenatide on Thyroid-Stimulating Hormone and Thyroid Volume","volume":"8","author":"Sencar","year":"2019","journal-title":"Eur. Thyroid J."},{"key":"ref_40","first-page":"275","article-title":"Exenatide Treatment Reduces Thyroid Gland Volume, but Has No Effect on the Size of Thyroid Nodules","volume":"16","author":"Berker","year":"2020","journal-title":"Acta Endocrinol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1786559","DOI":"10.1155\/2022\/1786559","article-title":"Effect of Liraglutide on Serum TSH Levels in Patients with NAFLD and Its Underlying Mechanisms","volume":"2022","author":"Ye","year":"2022","journal-title":"Int. J. Clin. Pract."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1007\/s00125-016-3874-y","article-title":"GLP-1 Receptors Exist in the Parietal Cortex, Hypothalamus and Medulla of Human Brains and the GLP-1 Analogue Liraglutide Alters Brain Activity Related to Highly Desirable Food Cues in Individuals with Diabetes: A Crossover, Randomised, Placebo-Controlled Trial","volume":"59","author":"Farr","year":"2016","journal-title":"Diabetologia"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1089\/thy.2023.0284","article-title":"GLP-1 Receptor Signaling Has Different Effects on the Perikarya and Axons of the Hypophysiotropic Thyrotropin-Releasing Hormone Synthesizing Neurons in Male Mice","volume":"34","author":"Ruska","year":"2024","journal-title":"Thyroid"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1210\/endo.137.10.8828468","article-title":"Glucagon-like Peptide-1 (GLP-1) Releases Thyrotropin (TSH): Characterization of Binding Sites for GLP-1 on Alpha-TSH Cells","volume":"137","author":"Beak","year":"1996","journal-title":"Endocrinology"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1507\/endocrj.EJ18-0140","article-title":"Association between Serum Thyrotropin within the Euthyroid Range and Obesity","volume":"66","author":"Zhang","year":"2019","journal-title":"Endocr. J."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e4251","DOI":"10.1210\/clinem\/dgab183","article-title":"Causal Association Between Serum Thyrotropin and Obesity: A Bidirectional, Mendelian Randomization Study","volume":"106","author":"Wang","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/cen.14901","article-title":"The GLP-1 Receptor Agonist Exenatide Reduces Serum TSH by Its Effect on Body Weight in People with Type 2 Diabetes","volume":"99","author":"Tee","year":"2023","journal-title":"Clin. Endocrinol."},{"key":"ref_48","unstructured":"Ganesan, K., Anastasopoulou, C., and Wadud, K. (2024). Euthyroid Sick Syndrome. StatPearls, StatPearls Publishing."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"927859","DOI":"10.3389\/fendo.2022.927859","article-title":"Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: A Meta-Analysis of Randomized Controlled Trials","volume":"13","author":"Hu","year":"2022","journal-title":"Front. Endocrinol."},{"key":"ref_50","unstructured":"(2024, January 29). FDA Victoza (Liraglutide) Injection, Available online: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/022341s027lbl.pdf."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"736","DOI":"10.2967\/jnumed.106.038679","article-title":"GLP-1 Receptor Expression in Human Tumors and Human Normal Tissues: Potential for in Vivo Targeting","volume":"48","author":"Waser","year":"2007","journal-title":"J. Nucl. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1210\/en.2009-1272","article-title":"Glucagon-Like Peptide-1 Receptor Agonists Activate Rodent Thyroid C-Cells Causing Calcitonin Release and C-Cell Proliferation","volume":"151","author":"Madsen","year":"2010","journal-title":"Endocrinology"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1177\/0192623315588999","article-title":"Effects of the GLP-1 Receptor Agonist Dulaglutide on the Structure of the Exocrine Pancreas of Cynomolgus Monkeys","volume":"43","author":"Vahle","year":"2015","journal-title":"Toxicol. Pathol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3803\/EnM.2014.29.4.536","article-title":"Expression of Glucagon-like Peptide-1 Receptor in Papillary Thyroid Carcinoma and Its Clinicopathologic Significance","volume":"29","author":"Jung","year":"2014","journal-title":"Endocrinol. Metab."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"620","DOI":"10.2337\/dc17-1956","article-title":"No Evidence of Increase in Calcitonin Concentrations or Development of C-Cell Malignancy in Response to Liraglutide for Up to 5 Years in the LEADER Trial","volume":"41","author":"Sherman","year":"2018","journal-title":"Diabetes Care"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"384","DOI":"10.2337\/dc22-1148","article-title":"GLP-1 Receptor Agonists and the Risk of Thyroid Cancer","volume":"46","author":"Bezin","year":"2023","journal-title":"Diabetes Care"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"221","DOI":"10.14715\/cmb\/2023.69.14.37","article-title":"GLP-1 Receptor Agonist Liraglutide Inhibits the Proliferation and Migration of Thyroid Cancer Cells","volume":"69","author":"Zhang","year":"2023","journal-title":"Cell Mol. Biol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/jcpt.13259","article-title":"Glucagon-like Peptide-1 Analogues and Thyroid Cancer: An Analysis of Cases Reported in the European Pharmacovigilance Database","volume":"46","author":"Mali","year":"2021","journal-title":"J. Clin. Pharm. Ther."},{"key":"ref_59","first-page":"403","article-title":"Glucagon-like Peptide-1 Receptor Agonists and Thyroid Cancer: A Narrative Review","volume":"34","author":"Brito","year":"2024","journal-title":"Thyroid"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/dom.15292","article-title":"Risk of Thyroid Cancer Associated with Glucagon-like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes: A Population-Based Cohort Study","volume":"26","author":"Bea","year":"2024","journal-title":"Diabetes Obes. Metab."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Feier, C.V.I., Vonica, R.C., Faur, A.M., Streinu, D.R., and Muntean, C. (2024). Assessment of Thyroid Carcinogenic Risk and Safety Profile of GLP1-RA Semaglutide (Ozempic) Therapy for Diabetes Mellitus and Obesity: A Systematic Literature Review. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25084346"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/dom.15382","article-title":"Glucagon-like Peptide-1 Receptor Agonists and Risk of Thyroid Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"26","author":"Silverii","year":"2024","journal-title":"Diabetes Obes. Metab."},{"key":"ref_63","first-page":"508","article-title":"Serum Thyroglobulin-A Sensitive Biomarker of Iodine Nutrition Status and Affected by Thyroid Abnormalities and Disease in Adult Populations","volume":"30","author":"Du","year":"2017","journal-title":"Biomed. Environ. Sci."}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/14\/6\/687\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:57:45Z","timestamp":1760108265000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/14\/6\/687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,13]]},"references-count":63,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["biom14060687"],"URL":"https:\/\/doi.org\/10.3390\/biom14060687","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,13]]}}}